Prevalence, prognostic importance and therapeutic implications of anemia in heart failure

Indian Heart Journal

Volumn 57, Issue 6, 2005, Pages 670-674

  Mishra, Trinath K ^a   Mishra, Sura K ^a   Mohanty, Nirmal K ^a   Rath, Pravin K ^a  

^a MKCG MEDICAL COLLEGE   (India)

Author keywords

Anemia; Erythropoietin; Heart failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERRIC GLUCONATE; FUROSEMIDE; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CARDIAC PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; EXERCISE TEST; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SURVIVAL;

AGE DISTRIBUTION; AGED; ANEMIA, IRON-DEFICIENCY; CASE-CONTROL STUDIES; COMORBIDITY; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33644684170     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, et al. The epidemiology of heart failure. Eur Heart J 1997; 18: 208-225
2. Cleland JG, Khand A, Clark A. The heart failure epidemic : exactly how big is it ? Eur Heart J 2001; 22: 623-626
3. Berry C, Murdoch DR, Mc Murray JJ. Economics of chronic heart failure. Eur J Heart Failure 2001; 3: 283-291
4. Mehra MR, Uber PA, Francis GS. Heart failure therapy at a crossroad: are there limits to the neurohormonal model ? J Am Coll Cardiol 2003; 41; 1606-1610
5. Felker GM, Adams KF Jr, Gattis WA, O'Connor CM. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 2004; 44: 959-966
6. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39: 1780-1786
7. Cromie N, Lee C, Struthers AD. Anaemia in chronic heart failure: what is its frequency in UK and its underlying causes ? Heart 2002; 87: 377-378
8. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000; 35; 1737-1744
9. Katz SD, Mancini D, Androne AS, Hryniewicz K. Treatment of anemia in patients with chronic heart failure. J Card Failure 2004; 10 (Suppl): 6-13
10. Silverberg DS, Wexler D, Iaina A. The role of anemia in progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron ? J Nephrol 2004; 17: 749-761
11. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure : the Framingham study. N Engl J Med 1971; 285: 1441-1446
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echochardiogr 1989; 2: 358-367
13. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, et al. Reduced kidney function and anemia as risk function for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 955-962
14. Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 2003; 92: 625-628
15. Szachniewicz J, Petruk-Kowalczyk J, Majda J, Kaczmarek A, Reczuch K, Kalra PR, et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 2003; 90: 303-308
16. Silverberg DS, Wexler D, Sheps D, Blum M, Keren G. Baruch R, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron : a randomized controlled study. J Am Coll Cardiol 2001; 37: 1775-1780
17. Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne AS. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003; 107: 294-299
18. Kalra PR, Bolger AP, Francis DP, Genth-Zotz S, Sharma R, Ponikowski PP, et al. Effect of anemia on exercise tolerance in chronic heart failure. Am J Cardiol 2003; 91: 888-891
19. Witte KK, Desilva R, Chattopadhyaya S, Ghosh J, Cleland JG, Clark AL. Are hematinic deficiencies the cause of chronic heart failure ? Am Heart J 2004; 147: 924-930
20. Chatterjee B, Nydegger UE, Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT (1) Antagonists. Eur J Heart Fail 2002; 2: 393-398
21. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology / American Heart Association Task Force on Practice guidelines (Committee to Revise the 1995 Guidelines for the evaluation and management of Heart Failure). J Am Coll Cardiol 2001; 38: 2101-2113